⚠ AI-Generated

The summary below was generated by an AI language model and may contain errors or omissions. All other content on this page is deterministically extracted from the original SEC EDGAR filing.

Prudential added one new risk disclosure in 2025 addressing morbidity risk, specifically the exposure to adverse deviations in incidence, utilization, or continuation experience across its insurance product portfolio. This addition represents an explicit biometric risk category that details potential manifestations affecting insurance operations. All other 11 existing risk disclosures from 2024 remained substantively unchanged.

Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.

🟢 New in Current Filing Certain of our insurance products are subject to morbidity risk, which is the risk that either incidence, utilization or continuation experience deviates adversely from what is expected. Morbidity risk is a biometric risk that can manifest in the following ways: 🔒

1 change in this historical filing

Historical year-over-year comparisons (2025 vs 2024 and earlier) are available on the Pro plan.

Get full access — from $29/month Already a Pro subscriber? View full diff →